0001104659-21-046732.txt : 20210405
0001104659-21-046732.hdr.sgml : 20210405
20210405201945
ACCESSION NUMBER: 0001104659-21-046732
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pirzkall Andrea
CENTRAL INDEX KEY: 0001818578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 21807713
MAIL ADDRESS:
STREET 1: C/O REPLIMUNE GROUP, INC.
STREET 2: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (781) 222-9600
MAIL ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
tm2112099-13_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-04-01
0
0001737953
Replimune Group, Inc.
REPL
0001818578
Pirzkall Andrea
C/O REPLIMUNE GROUP, INC.
500 UNICORN PARK
WOBURN
MA
01801
0
1
0
0
Chief Medical Officer
Common Stock
2021-04-01
4
A
0
20500
0
A
21500
D
Employee Stock Option (right to buy)
31.58
2021-04-01
4
A
0
30750
0
A
2031-04-01
Common Stock
30750
30750
D
Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2022 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2025, subject to the Reporting Person's continuous service to the Issuer.
1,000 shares of the Issuer's common stock are held by the Reporting Person's husband. The Reporting Person may be deemed to be the beneficial owner of such shares.
25% of the shares underlying this stock option vest on April 1, 2022, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
/s/ Jean Franchi, attorney-in-fact
2021-04-05